Collaboration with Industry – Protocol Development in MPS and Other Rare Disease Clinical Trials

Re-watch the informative conversation with Elsa Shapiro, PhD and Paul Harmatz, MD, on the unique role of the consulting psychologist, building partnerships within the greater trial ecosystem, and considerations for protocol development.